News & Perspective

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Oct 15, 2012

Oct 15, 2012

Report: Complacency, misperception stymie quest for better flu vaccines

The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.

Oct 15, 2012

A game-changing approach to investigating flu vaccines

Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

Jun 21, 2012

Jun 21, 2012

Fouchier study reveals changes enabling airborne spread of H5N1

(CIDRAP News) – A study showing that it takes as few as five mutations to turn the H5N1 avian influenza virus into an airborne spreader in mammals—and that launched a historic debate on scientific accountability and transparency—was released today in Science, spilling the full experimental details that many experts had sought to suppress out of concern that publishing them could lead to the unleashing of a dangerous virus.

Jan 30, 2012

Jan 30, 2012

Battle over H5N1 research continues in media, journals

(CIDRAP News) – The battle over dissemination of controversial research on mutant H5N1 avian influenza viruses continued in a flurry of commentaries and media letters in recent days, covering the full range of issues from the potential public health benefits to scientific censorship and the risk of bioterrorist exploitation of the findings.

Jan 23, 2012

Jan 23, 2012

Experts debate aspects of H5N1 transmission studies

(CIDRAP News) – More experts weighed in recently on various aspects of yet-unpublished H5N1 avian influenza transmissibility studies that have raised concerns about the risk of an intentional or accidental release of the mutant pathogens, as well as worries about scientific censorship.

Jan 20, 2012

Jan 20, 2012

Researchers announce pause in controversial H5N1 studies

(CIDRAP News) – Leading influenza researchers from around the world, faced with a relentless controversy over experiments dealing with potentially dangerous H5N1 viruses, today announced a 60-day pause in such research to allow time to discuss its risks, benefits, and oversight.

Jan 17, 2012

Jan 17, 2012

WHO to lead talks on controversial H5N1 studies

(CIDRAP News) – A World Health Organization (WHO) official said the agency will play a role in leading discussions on issues related to controversial H5N1 avian influenza transmission studies, as more experts called for a further global discussion of the issues.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»